VJET NYSE Surgical & Medical Instruments & Apparatus Financials FY2017βFY2025
Flyte Aviation, Inc. had $0.8M of revenue in fiscal 2025, up 95.0% on the year before. Over five years, revenue changed β28.6% a year on average.
Last close Β· Oct 23, 2026
$0.71
1.0%Hi! I read Flyte Aviation, Inc.βs latest annual report (fiscal 2025). Here is what stands out:
Good So-so Weak
Are sales growing?
+95.0%
Yes. Sales grew 95.0% last year.
Does it make a profit?
β2,098.0%
No. It lost money last year.
Does profit turn into cash?
β1,015.0%
No. It spent more cash than it brought in.
How healthy are the accounts?
3 / 7
Weak. It passes 3 of 7 health tests.
Rules of thumb on reported numbers. A starting point, not a recommendation.
Is it selling more, and how much does it keep?
In plain words: Every quarter, companies publish how much they sold and earned. These are the days Flyte Aviation, Inc. did it, and the next one. Share prices often move a lot on those days.
Next results
November 12, 2026
Thursday Β· in 17 days
| Date | Results for | Time | Source |
|---|---|---|---|
| Oct 12, 2026 | Period ended Sep 30, 2026 | Time not announced | 8-K β |
| Aug 14, 2026 | Q2 '26 | After the market closes | 10-Q β |
| May 18, 2026 | Q1 '26 | After the market closes | 8-K β |
| Mar 31, 2026 | Q4 '25 | After the market closes | 8-K β |
| Nov 13, 2025 | Q3 '25 | Time not announced | 8-K β |
| Aug 11, 2025 | Q2 '25 | After the market closes | 8-K β |
| Apr 22, 2025 | Q1 '25 | After the market closes | 8-K β |
| Mar 28, 2025 | Q4 '24 | Time not announced | 8-K β |
From SEC filings: the results press release (8-K) or, without one, the quarterly or annual report.
KIRA Β· Flyte Aviation, Inc. had $0.8M of revenue in fiscal 2025, up 95.0% on the year before. Over five years, revenue changed β28.6% a year on average. Its operating margin was β2,581.6%, up 95.3Β pts: of every 100 in sales, about β2,582 is left after running the business.
In plain words: Revenue is all the money customers paid. The margins show how many cents of each dollar of sales are left over at each step: after making the product (gross), after running the business (operating) and after everything, tax included (net).
Revenue
Revenue
Margins, % of revenue
Margins, % of revenue
KIRA Β· Flyte Aviation, Inc. lost $17.2M in fiscal 2025.
Loss periods are shown in red.
In plain words: Net income is the profit left after every cost and tax. Earnings per share (EPS) splits that profit across every share, so it shows what one share earned.
Net income
Net income
Diluted EPS
How much cash comes in, and where does it go?
KIRA Β· Free cash flow was β$8.3M in fiscal 2025, β1,015.0% of revenue.
Cash from operations minus capital spending.
In plain words: Profit on paper is not the same as cash in the bank. Free cash flow is the cash left after paying to run and maintain the business: the money it can hand back to shareholders, save or invest.
Free cash flow
Free cash flow
Cash from operations vs capital spending
Cash from operations vs capital spending
In plain words: Companies hand cash back in two ways: dividends (cash paid to shareholders) and buybacks (buying back their own shares, so each remaining share owns a bigger slice).
Dividends and buybacks
Diluted shares outstanding (annual)
KIRA Β· No open-market insider trades in the last 12 months.
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. βPlanβ marks trades under a pre-arranged Rule 10b5-1 plan.
In plain words: Insiders are the people who run or own a big part of the company. Buying with their own money can signal confidence; selling often has personal reasons, like taxes or diversifying.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Can it carry its debts, and how well does it use its money?
KIRA Β· Flyte Aviation, Inc. owes $3.0M more than it holds in cash.
Cash, debt and the ratios that show how comfortably Flyte Aviation, Inc. can carry it.
In plain words: What the company owns and what it owes. More cash than debt is a cushion for bad times; a lot of debt leaves less room when business slows down.
Cash vs debt (incl. leases)
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $15.0M | $15.9M | $3.6M | $2.9M | $0.1M |
| Debt incl. finance leases | β | β | β | β | $3.1M |
| Debt / equity | β | β | β | β | 0.4x |
| Current ratio | 3.2x | 2.2x | 1.7x | 1.5x | 0.1x |
| Quick ratio | 3.0x | 2.2x | 1.7x | 1.5x | 0.1x |
| Total assets | $21.0M | $16.8M | $30.7M | $27.8M | $15.9M |
| Total liabilities | $7.4M | $7.6M | $9.5M | $16.0M | $9.2M |
| Shareholders' equity | $13.7M | $9.3M | $21.2M | $11.8M | $7.1M |
| Net debt (β = net cash) | β | β | β | β | $3.0M |
KIRA Β· Its return on capital was β166.3%: every 100 invested in the business earned about β166 in a year.
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
In plain words: How much profit the business makes on the money put into it. A higher percentage means each dollar invested works harder.
Return on capital, equity and assets (annual)
KIRA Β· Flyte Aviation, Inc. passes 3 of 7 financial health tests (Piotroski F-score).
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
In plain words: Nine yes/no tests of financial health, one point each. A green tick is a pass: 7 to 9 points is solid, 0 to 3 is weak.
| Test | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 3 / 9 | 2 / 8 | 1 / 8 | 2 / 8 | 3 / 7 | 3 / 7 | 3 / 7 |
| Accruals ratio | β108.6% | β28.9% | β40.3% | β20.0% | 9.4% | β22.7% | β210.0% | β25.2% | β40.7% |
| Altman Z'' | β15.20 | 9.69 | β9.94 | β16.35 | β31.37 | β45.59 | β43.63 | β36.02 | β73.23 |
Every number, year by year.
Amounts in USD. Hover a ratioβs name for its definition.
In plain words: Every number we have, year by year. Download it as a spreadsheet if you want to dig deeper.
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | $5.9M | $6.3M | $7.2M | $4.4M | $0.0M | $0.0M | $0.4M | $0.4M | $0.8M |
| Gross profit | $1.7M | $2.1M | β$1.7M | β$1.9M | β$1.5M | β$0.1M | $0.4M | $0.4M | $0.8M |
| Research and development | $4.5M | $2.8M | $4.5M | $9.0M | $12.3M | $6.4M | $0.5M | $0.3M | $0.9M |
| Operating income | β$17.8M | β$31.2M | β$57.7M | β$35.4M | β$29.3M | β$27.0M | β$78.1M | β$11.2M | β$21.1M |
| Interest expense | $0.0M | $0.0M | $0.3M | $0.1M | β | β | β | β | β |
| Pretax income | β$17.8M | β$30.8M | β$56.9M | β$35.3M | β$27.3M | β$26.9M | β$70.6M | β$13.5M | β$19.5M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $3.1M | β$1.8M |
| Net income | β$17.8M | β$30.8M | β$57.0M | β$36.0M | β$25.1M | β$26.9M | β$70.6M | β$16.6M | β$17.2M |
| Net income to common | β | β | β | β | β | β | β$71.4M | β$21.8M | β$17.2M |
| Diluted EPS | β$2.35 | β$3.34 | β$108.28 | β$21.22 | β$248.22 | β$25.98 | β | β | β |
| Diluted shares | 0.01B | 0.01B | 0.00B | 0.00B | 0.00B | 0.00B | β | β | β |
| Cash flow | |||||||||
| Cash from operations | β$5.5M | β$18.5M | β$33.2M | β$28.3M | β$27.6M | β$22.6M | β$20.6M | β$9.3M | β$8.3M |
| Capital expenditure | $0.5M | $0.6M | $0.3M | $0.1M | $0.3M | $0.0M | $0.1M | $0.1M | $0.0M |
| Free cash flow | β$6.1M | β$19.1M | β$33.4M | β$28.4M | β$27.9M | β$22.6M | β$20.7M | β$9.3M | β$8.3M |
| Depreciation and amortization | $0.2M | $0.6M | $1.8M | $2.4M | $1.6M | $0.4M | $2.1M | $2.1M | $2.1M |
| Stock-based compensation | $12.7M | $14.7M | $23.5M | $4.1M | $2.2M | $0.4M | $1.2M | $0.1M | $0.3M |
| Balance sheet | |||||||||
| Cash and short-term investments | $8.2M | $64.3M | $14.6M | $23.9M | $15.0M | $15.9M | $3.6M | $2.9M | $0.1M |
| Total debt | β | $0.9M | $0.6M | β | β | β | β | β | $3.1M |
| Current assets | $10.0M | $69.2M | $36.0M | $27.6M | $17.1M | $16.8M | $4.2M | $3.3M | $0.4M |
| Current liabilities | $2.6M | $6.0M | $6.8M | $7.8M | $5.4M | $7.6M | $2.5M | $2.2M | $3.9M |
| Inventory | $1.2M | $2.1M | $2.8M | $0.9M | $1.0M | $0.0M | $0.0M | $0.0M | $0.1M |
| Property and equipment, net | $1.2M | $4.8M | $5.1M | $2.5M | $1.8M | $0.0M | $0.1M | $0.1M | $0.1M |
| Goodwill | β | β | β | β | β | $0.0M | $0.0M | β | $0.0M |
| Intangible assets | β | β | β | β | β | $0.0M | $26.3M | $24.3M | $15.2M |
| Total assets | $11.3M | $74.0M | $44.1M | $33.4M | $21.0M | $16.8M | $30.7M | $27.8M | $15.9M |
| Total liabilities | $18.9M | $7.3M | $10.9M | $12.3M | $7.4M | $7.6M | $9.5M | $16.0M | $9.2M |
| Shareholders' equity | β$7.6M | $66.7M | $33.2M | $21.1M | $13.7M | $9.3M | $21.2M | $11.8M | $7.1M |
| Margins | |||||||||
| Gross margin | 29.0% | 32.8% | β22.9% | β43.4% | β6,990.9% | β1,050.0% | 93.2% | 90.0% | 92.3% |
| Operating margin | β302.6% | β498.0% | β801.9% | β803.7% | β133,027.3% | β192,578.6% | β17,674.0% | β2,676.9% | β2,581.6% |
| EBITDA margin | β298.8% | β488.0% | β777.6% | β750.0% | β125,913.6% | β189,571.4% | β17,204.5% | β2,174.8% | β2,323.3% |
| Net margin | β302.6% | β492.8% | β791.2% | β818.3% | β113,954.5% | β191,892.9% | β15,966.5% | β3,962.6% | β2,098.0% |
| FCF margin | β103.4% | β305.1% | β464.5% | β644.1% | β126,772.7% | β161,321.4% | β4,682.1% | β2,223.3% | β1,015.0% |
| Returns | |||||||||
| Return on capital | β | β754.9% | β238.5% | β | β | β | β | β | β166.3% |
| Return on capital employed | β205.7% | β45.8% | β154.9% | β137.9% | β187.0% | β291.2% | β276.4% | β44.0% | β176.9% |
| Return on equity | β | β104.3% | β114.1% | β132.8% | β144.0% | β234.3% | β463.5% | β101.0% | β182.7% |
| Return on assets | β157.6% | β72.3% | β96.4% | β93.0% | β92.0% | β141.8% | β296.7% | β56.9% | β78.8% |
| Return on tangible equity | β | β46.2% | β171.8% | β170.4% | β183.4% | β290.1% | β | β | β |
| Growth | |||||||||
| Revenue growth | β | 6.6% | 15.1% | β38.8% | β99.5% | β36.4% | 3,057.1% | β5.0% | 95.0% |
| Share count change | β | 22.3% | β94.3% | 223.0% | β94.1% | 923.8% | β | β | β |
| Financial health | |||||||||
| Debt / equity | β | 0.0x | 0.0x | β | β | β | β | β | 0.4x |
| Interest coverage | β4,440.0x | β2,225.7x | β230.9x | β327.8x | β | β | β | β | β |
| Current ratio | 3.8x | 11.6x | 5.3x | 3.6x | 3.2x | 2.2x | 1.7x | 1.5x | 0.1x |
| Quick ratio | 3.4x | 11.3x | 4.9x | 3.4x | 3.0x | 2.2x | 1.7x | 1.5x | 0.1x |
| Capital allocation | |||||||||
| Capex / revenue | 9.3% | 9.3% | 3.7% | 1.5% | 1,204.5% | 121.4% | 17.2% | 16.0% | 2.1% |
| Stock comp / revenue | 216.5% | 235.4% | 327.0% | 92.7% | 10,168.2% | 3,192.9% | 275.3% | 12.9% | 41.3% |
| Quality scores | |||||||||
| Piotroski F-score | β | 4.0 | 3.0 | 2.0 | 1.0 | 2.0 | 3.0 | 3.0 | 3.0 |
| Altman Z'' | β15.2 | 9.7 | β9.9 | β16.3 | β31.4 | β45.6 | β43.6 | β36.0 | β73.2 |
| Accruals ratio | β108.6% | β28.9% | β40.3% | β20.0% | 9.4% | β22.7% | β210.0% | β25.2% | β40.7% |
Source: SEC EDGAR XBRL filings (CIK 0001716621). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.
